02/05/2026
More than 80% of generic drugs used in the U.S. are manufactured overseas, often in facilities inspected less frequently than domestic plants. The FDA typically relies on these manufacturers to self-report and regulate, rather than conduct their own routine independent testing, leading to lax oversight. A new study from Ohio State University found that generic drugs manufactured overseas are linked to significantly more "severe adverse events" for patients who use them compared to equivalent drugs produced in the United States.
Generic drugs manufactured in India are linked to significantly more “severe adverse events” for patients who use them than equivalent drugs produced in the United States, a new study finds.These adverse events included hospitalization, disability, and in a few cases, death. Researchers found ...